Minister for Exports Congratulates ApconiX Minister for Exports, Mike Freer congratulated ApconiX for being honoured with the Queen's Award for Enterprise. The three Directors and Co-founders, Dr Richard Knight, Dr Michael Morton and Professor Ruth Roberts are all delighted that their hard work and determination and that of the whole team at ApconiX has [...]
Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions Dr Sean Hammond, as a member of an interdisciplinary team, has recently published the third of a series of papers seeking to unravel mechanistic and clinical aspects of the immunological drug-drug interactions that occur with immune checkpoint inhibitors. Immunotoxicology [...]
The Importance of "Agility" Post COVID In 2021, we shared our whole-hearted agreement with the 2020 Forbes Article describing agility as the new superpower. Agility certainly allowed ApconiX to thrive and grow during the pandemic by focusing on the science and on people rather than on any pre-existing plans or process, allowing our [...]
ApconiX Is Recruiting a Target Safety Biologist The closing date for this job vacancy has passed. Please visit our Come and Join Us page for current vacancies. If you believe you have the skills and experience and would like to become part of our team please send your speculative CV to careers@apconix.com ApconiX [...]
Christmas? Is it Late or Is it Early? The years pass so quickly and yes it's Christmas once again! ApconiX had to cancel their Christmas celebrations because of the surge in Covid19 infections over Christmas so we decided to postpone rather than cancel it. May 30th was unofficially renamed Christmas Day and Secret Santa [...]
ApconiX is Co-organising a One Day BTS Discovery Toxicology 2022 Event Dr Nicholas Coltman and Professor Ruth Roberts are co-organising the Science-led Strategies for Success in Discovery & Development Toxicology on Wednesday 15th June 2022 at the Alderley Park Conference Centre in Cheshire. ApconiX is co-organising the event with [...]
ApconiX Is Recruiting a Business Development Assistant The closing date for this job vacancy has passed. Please visit our Come and Join Us page for current vacancies. If you believe you have the skills and experience and would like to become part of our team please send your speculative CV to careers@apconix.com ApconiX [...]
New Paper Published in Birth Defects Research Dr Jane Barber, Dr Claire Sadler and Dr Jane Stewart are among the authors of new paper published in Birth Defects Research. The Paper Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition Abstract Background MMV390048 is [...]
DDTSS “Paper of the Year” Award Webinar The Drug Discovery Toxicology Specialty Section (DDTSS) DDTSS is hosting a webinar entitled “Species-specific urothelial toxicity with an anti-HIV noncatalytic site integrase inhibitor (NCINI) is related to unusual pH-dependent physicochemical changes" to present the work that was published in Toxicological Sciences and [...]
ApconiX Wins the Queen’s Award for Enterprise ApconiX is delighted to be honoured with a Queen’s Award for Enterprise. Announced today (21st April) ApconiX has been recognised for its excellence in International Trade. ApconiX was founded by Dr Richard Knight, Professor Ruth Roberts and Dr Michael Morton, ex-AstraZeneca colleagues [...]
